155 related articles for article (PubMed ID: 32209705)
1. Importance of Nebulizer Drying for Patients With Cystic Fibrosis.
Moore JE; Moore RE; Bell J; Millar BC
Respir Care; 2020 Oct; 65(10):1443-1450. PubMed ID: 32209705
[TBL] [Abstract][Full Text] [Related]
2. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of the
Moore JE; Millar BC
Int J Mycobacteriol; 2020; 9(2):173-175. PubMed ID: 32474539
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
Hohenwarter K; Prammer W; Aichinger W; Reychler G
J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
[TBL] [Abstract][Full Text] [Related]
6. Nebulizer cleaning and disinfection practices in families with cystic fibrosis: The relationship between attitudes, practice and microbe colonization.
Murray TS; O'Rourke TK; Feinn R; Drapeau G; Collins MS
J Cyst Fibros; 2019 Nov; 18(6):823-828. PubMed ID: 31126899
[TBL] [Abstract][Full Text] [Related]
7. Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers.
Harris JC; Collins MS; Huang PH; Schramm CM; Nero T; Yan J; Murray TS
Microbiol Spectr; 2022 Feb; 10(1):e0253521. PubMed ID: 35107362
[TBL] [Abstract][Full Text] [Related]
8. Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations.
Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Aghdam MK; Lotfollahzadeh S; Hosseini A; Dara N; Nanbakhsh M; Gorji FA
BMC Pulm Med; 2020 Feb; 20(1):33. PubMed ID: 32028925
[TBL] [Abstract][Full Text] [Related]
9. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
[TBL] [Abstract][Full Text] [Related]
10. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
[TBL] [Abstract][Full Text] [Related]
11. The effects of nebulizer hygiene training on the practices of cystic fibrosis patients and caregivers.
Yilmaz Yegit C; Ergenekon AP; Mursaloglu HH; Cenk M; Uzunoglu BS; Tastan G; Gokdemir Y; Erdem Eralp E; Karakoc F; Nasr SZ; Karadag B
Pediatr Pulmonol; 2021 Jun; 56(6):1527-1533. PubMed ID: 33538406
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
[TBL] [Abstract][Full Text] [Related]
13. Inhalation equipment hygiene: a belgian national survey.
Reychler G; Bosschaerts M; Chevaillier J; Gaspar V; Lessire F; Opdekamp C; Van Ginderdeuren F; Vanlaethem S; Vreys M; Vrijsen B;
J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):239-43. PubMed ID: 19466909
[TBL] [Abstract][Full Text] [Related]
14. New nebulizer technology to monitor adherence and nebulizer performance in cystic fibrosis.
McCormack P; Southern KW; McNamara PS
J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):307-9. PubMed ID: 22856641
[TBL] [Abstract][Full Text] [Related]
15. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
[TBL] [Abstract][Full Text] [Related]
16. Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output.
Collins MS; O'Brien M; Schramm CM; Murray TS
J Cyst Fibros; 2019 Mar; 18(2):233-235. PubMed ID: 30224332
[TBL] [Abstract][Full Text] [Related]
17. Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.
Della Zuana A; Garcia Dde O; Juliani RC; Silva Filho LV
J Bras Pneumol; 2014; 40(2):119-27. PubMed ID: 24831395
[TBL] [Abstract][Full Text] [Related]
18. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
[TBL] [Abstract][Full Text] [Related]
19. Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.
Hamed K; Debonnett L
Ther Adv Respir Dis; 2017 May; 11(5):193-209. PubMed ID: 28470103
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of Pseudomonas aeruginosa in waters: implications for patients with cystic fibrosis (CF).
Caskey S; Stirling J; Moore JE; Rendall JC
Lett Appl Microbiol; 2018 Jun; 66(6):537-541. PubMed ID: 29537700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
